Melinta on SPi NewsFollow our SPi News RSS Feed for melinta

Featured melinta News

[07 Nov 2018] Melinta Therapeutics Reports Third Quarter 2018 Financial Results

[31 Oct 2018] UPDATE - Melinta Therapeutics Announces Appointment of Bruce L. Downey to Board of Directors

[31 Oct 2018] Melinta Therapeutics Announces Appointment of Bruce L. Downey to Board of Directors

[22 Oct 2018] Melinta Therapeutics Announces Appointment of John H. Johnson as Interim Chief Executive Officer

[02 Oct 2018] Melinta Therapeutics Publishes Complete Results from Phase III TANGO 2 Study of Vabomere™ (meropenem and vaborbactam)

[25 Sep 2018] Melinta Therapeutics to Present at Upcoming Investor Conferences

[24 Sep 2018] Melinta Therapeutics to Give New Presentations on Antibiotics Portfolio and Pipeline at IDWeek™ 2018

[21 Sep 2018] Melinta Therapeutics Receives Positive CHMP Opinion for Vabomere™ (meropenem and vaborbactam)

[18 Sep 2018] Melinta Therapeutics Names Peter Milligan as Chief Financial Officer

[06 Sep 2018] Melinta Therapeutics to Host Meetings at the Morgan Stanley 16th Annual Global Healthcare Conference

[29 Aug 2018] Melinta Therapeutics to Present at the Rodman & Renshaw 20th Annual Global Investment Conference

[07 Aug 2018] Melinta Therapeutics Reports Second Quarter 2018 Financial Results

[03 Aug 2018] Melinta Therapeutics Announces Vabomere™ (meropenem and vaborbactam) Granted New Technology Add-On Payment by CMS

[13 Jun 2018] Melinta Therapeutics to Present at the JMP Securities Life Sciences Conference

[31 May 2018] Melinta Therapeutics Demonstrates Breadth of Commercial and Clinical Programs with 20 Presentations at ASM Microbe 2018

[24 May 2018] Melinta Therapeutics to Present at the Jefferies 2018 Global Healthcare Conference

[24 May 2018] Melinta Therapeutics Announces Pricing of Public Offering of Common Stock

[21 May 2018] Melinta Therapeutics Announces Proposed Offering of Common Stock

[11 May 2018] Melinta Therapeutics Launches New Antibiotic Stewardship Program to Combat Growing Threat of Antimicrobial Resistance

[08 May 2018] Melinta Therapeutics Reports First Quarter 2018 Financial Results

[08 May 2018] Melinta Therapeutics to Highlight Commitment to Antibiotics and Product Portfolio at MAD-ID 2018 Annual Meeting

[14 Mar 2018] Melinta Therapeutics to Present at Needham & Company’s 17th Annual Healthcare Conference

[13 Mar 2018] Melinta Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results

[02 Mar 2018] Melinta Therapeutics to Present at The Cowen and Company 38th Annual Health Care Conference

[29 Jan 2018] Melinta Therapeutics Launches Antibiotic Baxdela™ (delafloxacin) in the United States

[18 Jan 2018] Melinta Therapeutics Announces Initiation of Program for Radezolid in Patients with Bacterial Vaginosis

[08 Jan 2018] Melinta Therapeutics Completes Acquisition of The Medicines Company’s Infectious Disease Portfolio

[03 Jan 2018] Melinta Therapeutics to Present at 36th Annual J.P. Morgan Healthcare Conference

[02 Jan 2018] Melinta Therapeutics Appoints Lisa DeFrancesco as Senior Vice President of Investor Relations

[06 Nov 2017] Melinta Therapeutics Announces Successful Completion of Merger

[01 Nov 2017] Melinta and Cempra Announce Accomplished Executive Leadership Team for Combined Organization

[10 Oct 2017] Melinta Therapeutics’ Topical Radezolid Well Tolerated in Phase 1 Study for Treatment of Acne

[28 Sep 2017] Cempra and Melinta Announce Expiration of Hart-Scott-Rodino Waiting Period for Proposed Merger

[01 Jun 2017] Melinta Therapeutics Presenting In Vivo and In Vitro Results from Baxdela Studies at ASM Microbe

[19 Apr 2017] Melinta Therapeutics Highlighting Activity of Baxdela as well as Progress on Macrolide and Pyrrolocytosine Candidates at ECCMID 2017

[02 Mar 2017] Melinta Therapeutics and Menarini Group Enter into Commercial and Co-Development Agreement for Delafloxacin in 68 Countries

[28 Feb 2017] Melinta Therapeutics Announces FDA Acceptance of Investigational New Drug Application for Topical Radezolid

[27 Feb 2017] Melinta Therapeutics Provides Baxdela NDA Update

[05 Jan 2017] Melinta Therapeutics’ New Drug Application for Baxdela Accepted for Filing by US FDA

[26 Oct 2016] Melinta Therapeutics’ Baxdela™ to be Featured in Six Poster Presentations at IDWeek 2016™

[24 Oct 2016] Melinta Therapeutics Submits Baxdela New Drug Application for Hospital-Treated Skin Infections

[14 Jun 2016] Melinta Therapeutics Presenting Results from Baxdela and ESKAPE Programs at ASM Microbe 2016 Meeting

[19 Apr 2016] Melinta Therapeutics Appoints Dr. Eugene Sun as Chief Executive Officer

[03 Mar 2016] Melinta Therapeutics to Present at BioCentury Future Leaders Conference

[23 Feb 2016] Melinta Therapeutics Appoints John Temperato President and Chief Operating Officer

[05 Jan 2016] Melinta Therapeutics to Present at 34th Annual J.P. Morgan Healthcare Conference

[19 Sep 2015] Melinta Therapeutics Demonstrates Potency of Delafloxacin against Bacteria Associated with Respiratory Tract Infections

[04 Sep 2014] Melinta Therapeutics Highlighting Delafloxacin and ESKAPE Candidates in Twelve Presentations at 2014 ICAAC Meeting

[14 Aug 2014] Melinta Therapeutics Bolsters Board of Directors with Appointment of Christopher Kiritsy

[17 Jun 2014] Melinta Therapeutics to Present at Annual JMP Securities Healthcare Conference


Still looking?

Type in your search term below and click Enter

World News from SPi

Sector Publishing Intelligence [SPi'] publishes financial news from around the world FAST. For breaking news announcements from companies, blogs and commentators, SPi provides up to the minute, integrated news on all aspects of financial markets and financial services.

The SPi Financial News Search gets results from our extensive news archives containing 10’s of thousands of news reports. Intelligent cross referencing of stories and background gives readers and researchers highly relevant related information about topics and businesses in the finance sector.

Trending financial topics highlight the most recent themes in the news. Thousands of financial topics can be followed using RSS, or join hundreds of SPis Financial News followers on Twitter for instant news as soon as it’s published on SPi. @SPiFinancialSvc

SPi's extensive database of corporate information shows company details alongside breaking corporate news from the world’s largest news providers.

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2018. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.
 
Privacy Policy | Terms and Conditions | Contact Us